Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer

NCT00040560 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

INDUSTRY

Sponsor class

Conditions

Lung Neoplasms
Carcinoma, Non-Small-Cell Lung
Brain Neoplasms
Metastases, Neoplasm

Interventions

DRUG: 111In-DAC
PROCEDURE: Diagnostic

Sponsor

Copharos